1. From ERα66 to ERα36: a generic method for validating a prognosis marker of breast tumor progression
   Clémence Chamard-Jovenin et al, 2015, BMC Systems Biology CrossRef
2. ER-α36 Promotes the Malignant Progression of Cervical Cancer Mediated by Estrogen via HMGA2
   Chunyan Wang et al, 2021, Frontiers in Oncology CrossRef
3. ERα36 – Another piece of the estrogen puzzle
   Kamil Sołtysik et al, 2015, European Journal of Cell Biology CrossRef
4. The roles of estrogen and estrogen receptors in gastrointestinal disease (Review)
   Changmei Chen et al, 2019, Oncology Letters CrossRef
5. Biological effects of xenoestrogens and the functional mechanisms via genomic and nongenomic pathways
   Zhi-Xiang Xu et al, 2017, Environmental Reviews CrossRef
6. Prognostic value of estrogen receptor α and estrogen receptor β in gastric cancer based on a meta-analysis and The Cancer Genome Atlas (TCGA) datasets
   Hua Ge et al, 2018, International Journal of Surgery CrossRef
7. Estrogenic endocrine disruptors: Molecular mechanisms of action
   Ryoiti Kiyama et al, 2015, Environment International CrossRef
8. Roles of G Protein-Coupled Receptors (GPCRs) in Gastrointestinal Cancers: Focus on Sphingosine 1-Shosphate Receptors, Angiotensin II Receptors, and Estrogen-Related GPCRs
   Zhen Zeng et al, 2021, Cells CrossRef
9. GRP78 positively regulates estrogen-stimulated cell growth mediated by ER-α36 in gastric cancer cells
   Zhengqi Fu et al, 2017, Molecular Medicine Reports CrossRef
10. Dual COX-2/5-LOX inhibitors from Zanthoxylum simulans inhibit gastric cancer cells by cross-mediating thyroid, estrogen, and oxytocin signaling pathways
    Yong-Qiang Tian et al, 2024, Frontiers in Chemistry CrossRef
11. Inhibitors Targeting Multiple Janus Kinases From Zanthoxylum simulans Mediate Inhibition and Apoptosis Against Gastric Cancer Cells via the Estrogen Pathway
    Yong-Qiang Tian et al, 2022, Frontiers in Chemistry CrossRef
12. Hypoxia, cytokines and stromal recruitment: parallels between pathophysiology of encapsulating peritoneal sclerosis, endometriosis and peritoneal metastasis
    Robert Beaumont Wilson, 2018, Pleura and Peritoneum CrossRef
13. Regulation of sex hormone receptors in sexual dimorphism of human cancers
    Daoshan Zheng et al, 2018, Cancer Letters CrossRef
14. Expression of estrogen receptors and androgen receptor and their clinical significance in gastric cancer
    Wenbo Tang et al, 2017, Oncotarget CrossRef
15. ER-α36 Interactions With Cytosolic Molecular Network in Acquired Tamoxifen Resistance
    Azin Teymourzadeh et al, 2017, Clinical Breast Cancer CrossRef
16. Effects of 17β-estradiol and tamoxifen on gastric cancer cell proliferation and apoptosis and ER-α36 expression
    Xuming Wang et al, 2017, Oncology Letters CrossRef
17. ER-α36 mediates estrogen-stimulated MAPK/ERK activation and regulates migration, invasion, proliferation in cervical cancer cells
    Qing Sun et al, 2017, Biochemical and Biophysical Research Communications CrossRef
18. Involvement of the Akt signaling pathway in ER-α36/GRP94-mediated signaling in gastric cancer
    ZHENGQI FU et al, 2014, Oncology Letters CrossRef
19. ER‐α36 is involved in calycosin inhibition of IL‐6 production in macrophages
    Guoli Wu et al, 2024, Journal of Cellular and Molecular Medicine CrossRef
20. Estrogen receptor variant ER‐α36 facilitates estrogen signaling via EGFR in glioblastoma
    Chao Qu et al, 2022, Cell Biology International CrossRef
21. Estrogen receptors in gastric cancer: Advances and perspectives
    Muhammad Saif Ur Rahman, 2016, World Journal of Gastroenterology CrossRef
22. Reprogramming of Mesothelial-Mesenchymal Transition in Chronic Peritoneal Diseases by Estrogen Receptor Modulation and TGF-β1 Inhibition
    Robert B. Wilson et al, 2020, International Journal of Molecular Sciences CrossRef
23. Nonmonotonic responses to low doses of xenoestrogens: A review
    Zhixiang Xu et al, 2017, Environmental Research CrossRef